Tegaserod maleate exhibits strong anti-AML effects by targeting TRPM8, This demonstrates that TRPM8 is a regulator of leukemia occurrence and has the potential to treat AML as a novel prognostic factor [86]. Here, TRPM8 is linked to acute myeloid leukemia.